US FDA Commissioner Admonishes Health Care Stakeholders To Know Agency Better, Help More
Executive Summary
Califf was candid during an FDA Science Board meeting about the agency’s limits, such as disseminating accurate information in response to rampant misinformation during COVID-19 pandemic. “We need to call out people who are outside the FDA … because this vast universe of information out there is way bigger than we can handle on our own,” he said.